InvestorsHub Logo

Biotech_Tradez

12/06/18 6:40 PM

#30240 RE: Craig305 #30239

I think they probably just got the $1.5m from the note holder who is now converting the note to get his money back. If they didn't pay off the note then the CEO of RGN would have gotten the tech back and kept the $3.0m they already paid him.

The dilution is nowhere near done. In fact, it is just starting as this company owes the toxic lender a lot of money and he has about $5 million in convertible notes that he still has to convert. He owns ENDV not the shareholders.

They increased the authorized to 2.5 billion shares for a reason. They plan to use all of those shares one way or another.

This is a buy below $0.02 per share not a fraction of a penny more.